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Previous studies from our laboratory identified cellular membrane proteins that mediate binding of visna virus to
susceptible cells. In the pilot report, antiserum raised to one of these proteins, ;45 kDa, was shown to both label the surface
of susceptible cells and block the binding of visna virus to cell membranes. In a recent study, we reported that the same
antiserum, designated 2-23, significantly inhibited infection by visna virus and specifically immunoprecipitated a membrane-
associated protein complex from susceptible cells, comprised of a ;45- kDa protein, as well as a 30-kDa protein. Because
the 30-kDa protein was readily detectable in TRANS[35S]-LABELed susceptible cells, we were able to characterize this
protein biochemically, as a chondroitin sulfate proteoglycan. In the present study, we sought to characterize the ;45-kDa
protein and examined 2-23 immune complexes for the presence of kinase activity. Our data indicate that although in vitro
kinase assays of 2-23 immunoprecipitates specifically result in the phosphorylation of the ;45-kDa protein as well as a novel
;56-kDa protein, only the ;45-kDa protein exhibits inherent serine/threonine kinase activity. In addition, the kinase activity
can be isolated in 2-23 immunoprecipitates of membranes prepared from visna virus-susceptible cells. Finally, in an effort
to evaluate the biological relevance of our in vitro observations, we examined 2-23 immunoprecipitates of [32P]orthophos-
phate-labeled visna-susceptible cells and report that the ;56-kDa protein is phosphorylated constitutively on serine in vivo.
Collectively, these data implicate a serine/threonine kinase complex in the binding/infection of visna virus. © 2000 Academic
Press
INTRODUCTION
The lentivirus family of retroviruses encompasses
visna virus, in addition to human immunodeficiency virus
(HIV), simian immunodeficiency virus (SIV), feline immu-
nodeficiency virus (FIV), equine infectious anemia virus
(EIAV), and caprine arthritic-encephalitis virus (CAEV).
The cellular receptors for these viruses are known only
for FIV, HIV, and SIV, each of which uses chemokine
receptors, to various degrees. For example, CXCR4 is
sufficient for FIV envelope fusion (Willett et al., 1997),
whereas receptor-mediated cell fusion by most strains of
HIV and SIV require CD4, in addition to CXCR4 or CCR5,
respectively (Broder and Collman, 1997; Broder and Dim-
itrov, 1996; Marx and Chen, 1998). Moreover, some SIV
strains can use chemokine receptors in the absence of
CD4 and are somewhat promiscuous in their abilities to
use more than one chemokine receptor, in the presence
or absence of CD4 (Edinger et al., 1997). In vivo, FIV, HIV,
and SIV infect both lymphocytes and macrophages, ulti-
mately culminating in acquired immune deficiency syn-
drome (AIDS) and organ-specific diseases in the lung,
central nervous system (CNS), and gastrointestinal tract
(Zink et al., 2000).1 To whom reprint requests should be addressed. Fax: (410) 955-
823. E-mail: jclement@jhmi.edu.
321The cellular receptors for visna virus, EIAV, and CAEV
have not yet been determined. In vivo, these viruses
infect predominantly macrophages but not lymphocytes,
and disease sequelae do not include AIDS but rather
manifest as dysregulated inflammatory responses in
joints, the CNS, and the lung (Clements and Zink, 1996).
Two candidate cellular receptors for visna virus have
been proposed previously, with one report implicating a
30-kDa protein (Dalziel et al., 1991), and a second impli-
cating a ;45-kDa protein (Crane et al., 1991). Proposal of
the 30-kDa protein was based on experiments in which
purified soluble ovine MHC II prevented visna virus bind-
ing to a 30-kDa protein on susceptible cells (Dalziel et al.,
1991). However, efforts to confirm the identity of the
30-kDa protein as MHC II were unsuccessful. Proposal
of the ;45-kDa protein (molecular weight approximated
because migration varied slightly between separative
techniques; J.E.C., personal communication) as a candi-
date receptor for visna virus originated in our laboratory
and was based on the results of a series of experiments
(Crane et al., 1991). First, visna virus was found to bind to
three membrane-associated proteins expressed specifi-
cally, in visna virus-susceptible sheep choroid plexus
(SCP) cells. Second, antiserum raised against each vi-
rus-binding protein was evaluated for the ability to (1)
label the cell surface of SCPs, (2) recognize the appro-
priate immunogen by Western blot analysis, (3) block the
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and (4) block the binding of visna virus to intact SCPs.
The only antiserum able to satisfy each requirement had
been raised against the ;45-kDa protein, and was des-
ignated “2-23.”
In a recent study, we extended our analyses of 2-23
and reported that 2-23 significantly reduced visna virus
infection of SCPs and immunoprecipitated a protein
complex from [14C]-labeled and TRANS[35S]-LABELed
SCPs, composed of a ;45-kDa protein, as well as a
;30-kDa protein (Bruett et al., 2000). Although inefficient
[35S] and [14C] radiolabeling of the ;45-kDa protein pro-
hibited biochemical analysis, we were able to character-
ize the membrane-associated 30-kDa protein as a chon-
droitin sulfate-substituted proteoglycan. The aim of the
present study was to characterize the ;45-kDa protein.
We reasoned that because many membrane proteins
activate specific agonist-induced signal transduction
pathways in cells, the 2-23 immune complex might con-
tain kinase activity. The results presented in this report
demonstrate that the ;45-kDa protein recognized by
2-23, is itself a membrane-associated serine/threonine
kinase and that a membrane-associated ;56-kDa pro-
tein is a preferred substrate of serine/threonine kinase
activity specifically immunoprecipitated by 2-23 from un-
gulate cells susceptible to productive infection by visna
virus. Further, analysis of 2-23 immunoprecipitates from
these cells, cultured in the presence of [32P]orthophos-
phate, indicate that the ;56-kDa protein is constitutively
phosphorylated. The previously described ;30-kDa pro-
tein was not phosphorylated under any experimental
condition. In conjunction with our previous reports, the
present findings support a role for a serine/threonine
kinase complex in the binding and/or infection of visna
virus.
RESULTS
The 45-kDa and ;56-kDa proteins are
phosphorylated in in vitro kinase assays of 2-23
immunoprecipitates
We have shown previously that antiserum 2-23 specif-
ically labels the surface of susceptible cells, blocks the
binding of visna virus to a ;45-kDa membrane protein,
significantly reduces visna virus infection of SCPs, and
immunoprecipitates a protein complex from [35S]- and/or
14C]-labeled SCPs composed of ;45- and 30-kDa pro-
eins (Bruett et al., 2000; Crane et al., 1991). In the latter
tudies, we were able to characterize the 30-kDa protein
s a proteoglycan containing chondroitin sulfate substi-
utions; however, the ;45-kDa protein was not efficiently
35S] and/or [14C] labeled, perhaps suggestive of a low
urnover rate. As an alternative approach to studying the
45-kDa protein, we considered the possibility that the
322 BARBER, BRUEembrane-associated protein complex immunoprecipi-
ated by 2-23 might contain kinase activity. To this end, in
t
iitro kinase assays were performed on 2-23 immunopre-
ipitates prepared from cells susceptible to productive
nfection by visna virus such as SCPs and goat synovial
embrane cells (GSM), as well as cells nonsusceptible
o productive infection by visna virus, such as quail cells
QT6) and murine fibroblasts (NIH3T3). Resolution of ki-
ase products by SDS–PAGE (Fig. 1A) indicates that only
-23 immunoprecipitates prepared from visna-suscepti-
le SCP and GSM cells contain a ;45-kDa phosphopro-
ein (pp) in addition to an extensively [32P]-labeled ;56-
Da pp. A specific pp representing the previously de-
cribed ;30-kDa protein was never detected in any
inase assay of 2-23 immunoprecipitates.
To compare the migration of the ;45-kDa protein with
that of the previously described ;45-kDa protein (Bruett
et al., 2000; Crane et al., 1991), 2-23 immunoprecipitates
prepared from unlabeled SCPs) processed for in vitro
inase assays were separated by SDS–PAGE alongside
-23 immunoprecipitates prepared from SCPs double
abeled with [35S]/[14C]. The results (Fig. 1B) indicate that
FIG. 1. (A) In vitro kinase assays of NRS or 2-23 immunoprecipitates
prepared from cells susceptible (SCPs, GSMs) and nonsusceptible
(QT6, 3T3) to productive visna virus infection. The 2-23 immunoprecipi-
tates prepared from equal amounts of protein extracted from the indi-
cated cells were processed in in vitro kinase assays as described
under Materials and Methods. The arrows indicate the positions of
2-23-specific pps migrating to ;45 and ;56 kDa. (B) Pre-2-23 or 2-23
mmunoprecipitates prepared from unlabeled SCPs processed in in
itro kinase assays were separated by SDS–PAGE alongside 2-23
mmunoprecipitates prepared from [35S]/[14C]-labeled SCPs, as de-
scribed under Materials and Methods. The arrows indicate the posi-
tions of 2-23-specific ;45- and ;56-kDa proteins. The asterisks rep-
resent the migration of a common nonspecific ;50-kDa protein de-
scribed in the text.
D CLEMENTShe 2-23-specific ;45-kDa and ;56-kDa pps comigrate
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KINASE;45-kDa and ;56-kDa proteins (Bruett et al., 2000). Of
note, detection of the ;56-kDa protein (not previously
described) in 2-23 immunoprecipitates of [35S]/[14C]-la-
beled cells is sensitive to SDS–PAGE conditions and
requires extensive autoradiographic exposure.
A ;50-kDa pp (indicated by * in Figs. 1A and 1B)
resent in both normal rabbit serum (NRS) and 2-23
mmunoprecipitates of all cell types examined is a
onspecific protein; the accelerated migration of this
rotein in 2-23 immunoprecipitates is caused by
nique immunoglobulin heavy chains present in the
-23 antiserum that push the ;50-kDa band further
into the gel, causing the band to bend into a charac-
teristic “smiling” pattern. Both ;50-kDa bands are ty-
rosine phosphorylated and migrate similarly when
separated in a second dimension by isoelectric focus-
ing, suggesting that both bands represent the same
protein (not shown).
Serine/threonine kinase activity is
immunoprecipitated by 2-23
To characterize the amino acid specificities of the
2-23-associated kinase or kinases, we first examined the
effects of two general kinase inhibitors by adding stau-
rosporine (serine/threonine kinase inhibitor; 10 mM),
enistein (tyrosine kinase inhibitor; 100 mM), or DMSO
(vehicle control; 1%, which represents the highest con-
centration of DMSO present in either inhibitor) to the
kinase buffer in in vitro kinase assays. Staurosporine
completely inhibited the kinase activity that phosphory-
lates the ;56-kDa protein, whereas DMSO (vehicle con-
trol) or genistein had no appreciable effect (Fig. 2A),
suggesting that 2-23 immunoprecipitates contain a
serine/threonine kinase or kinases. The faint band in the
NRS lane migrates just above the ;56-kDa band in lower
percentage gels as seen in other figures of SCPs (Figs.
1A and 1B). Phosphoamino acid analysis of the ;56-kDa
pp confirmed the presence of phosphoserine (Fig. 2B).
Phosphoamino acid analysis of the ;45-kDa pp was not
assessed in these studies because pp45 was only barely
detectable, relative to pp56, in the initial SDS–PAGE step
of the procedure (Fig. 2A) and required prolonged radio-
graphic exposure simply to identify the band for excision,
thereby prohibiting further processing (longer exposure
not shown).
The 45-kDa protein is a serine/threonine kinase
In vitro kinase assays are able to identify proteins
phosphorylated de novo but are unable to distinguish
inases from substrates. To determine whether either or
oth ;45- and ;56-kDa proteins are kinases, we per-
ormed in gel kinase assays on 2-23 immunoprecipitates
eparated by SDS–PAGE through polyacrylamide gels
SERINE/THREONINEolymerized with or without 200 mg/ml myelin basic
rotein (MBP), a classic substrate for many serine/thre-nine kinases (Fig. 3A). In gels without MBP, a single
ight band appears at ;45-kDa, only in 2-23 immunopre-
ipitates, indicating that the ;45-kDa protein is itself a
inase with limited ability to autophosphorylate. This
inding is consistent with the disproportionate incorpo-
ation of [32P] by the 45-kDa protein in in vitro kinase
ssays (relative to ;pp56; Figs. 1 and 2). In gels con-
aining MBP, a single band of ;45-kDa is present spe-
ifically in 2-23 immunoprecipitates, and relative to the
45-kDa band observed in gels without MBP, the inten-
ity of the ;45-kDa band is greatly increased, indicating
he ability of the ;45-kDa kinase to phosphorylate MBP.
ased on the enhanced detection of the ;45-kDa protein
inase, in gel kinase assays were used to assess the
resence of the ;45-kDa protein kinase in subsequent
experiments.
Phosphoamino acid analysis of the ;45- kDa band
isolated from the gel containing MBP (which consists
predominantly of phosphorylated MBP, with some auto-
phosphorylated kinase) indicates the presence of phos-
phoserine and phosphothreonine (Fig. 3B).
To assess the effect of various inhibitors on ;45-kDa
FIG. 2. (A) In vitro kinase assays of NRS immunoprecipitates or 2-23
immunoprecipitates processed in in vitro kinase assays performed in
the presence or not of DMSO (1%), staurosporine (10 mM), or genistein
(100 mM), as described under Materials and Methods. The arrow
indicates the position of the ;56-kDa pp. (B) Phosphoamino acid
analysis of the ;56-kDa pp isolated from the 2-23-specific, untreated
lane in the in vitro kinase gel represented in A. The positions of the
phosphoamino acid standards are indicated.
323AND VISNA VIRUSprotein kinase activity, in gel kinase assays were per-
formed on 2-23 immunoprecipitates separated by SDS–
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3 TT, ANPAGE in gels containing MBP and processed in control
buffers (ND) or buffers supplemented with DMSO (D; 1%),
staurosporine (S; 10 mM), or genistein (G; 100 mM; see
aterials and Methods). The absence of the ;45-kDa pp
nly in gels treated with staurosporine demonstrates the
ensitivity of the ;45-kDa protein kinase to staurospor-
ne (Fig. 3C).
resence of the ;45 kDa kinase activity correlates
ith virus entry
In vitro kinase assays of 2-23 immunoprecipitates pre-
ared from NIH3T3 cells and QT6 cells, neither of which
upport productive visna virus replication, indicated the
bsence of the ;56 kDa major kinase substrate (Fig. 1A).
owever, due to the inefficient autophosphorylation ex-
ibited by the ;45 kDa kinase in these assays, the
esults did not exclude the possibility that these cells
ontain suboptimal levels of ;45 kDa kinase activity.
ence, we performed in gel kinase assays of 2-23 im-
FIG. 3. (A) In gel kinase assays performed on NRS or 2-23 immuno-
recipitates prepared from SCPs or GSMs, separated by SDS–PAGE in
els containing (right) or not (left), the substrate MBP. The arrows
ndicate the position of the ;45-kDa kinase. (B) Phosphoamino acid
nalysis of the ;45-kDa pp isolated from the lane representing 2-23
mmunoprecipitates prepared from GSMs in the in gel kinase assay
hown in A. (C) In gel kinase assays of NRS or 2-23 immunoprecipitates
repared from SCPs and processed for in gel kinase assays in the
bsence (no drug; ND) or presence of DMSO (D), genistein (G), or
taurosporine (S) as described under Materials and Methods.
24 BARBER, BRUEunoprecipitates prepared from both cell lines. The re-
ults (Fig. 4A) indicate low, but detectable, 2-23-specific
a
t45 kDa kinase activity in QT6 cells but not in NIH3T3
ells.
To evaluate the relevance of the ;45 kDa kinase
ctivity in QT6 cells to virus entry (considering the pos-
ibility that failure of QT6 cells to support productive
isna virus replication is manifested at a postentry
hase), we infected SCP, QT6, and NIH3T3 cells with 106
TCID50 of visna virus and amplified newly synthesized
iral DNA using primers specific for the 59 region of the
isna gag gene. Cells were infected for 3 h and time
oints were taken at the time of infection (0 h) and 3, 8,
nd 24 h postinfection (p.i.). SCP cells were used as a
ositive control in this experiment, because they support
roductive infection by visna virus. In lysates of infected
CP cells, PCR products for gag can be detected as early
s 8 h p.i. (Fig. 4B, top arrow). PCR products for gag were
etected at 24 h p.i. in lysates of infected QT6 cells (Fig.
B, middle arrow). These cells were previously thought to
e nonpermissive to visna virus infection (Bruett et al.,
000); however, these PCR data suggest that QT6 cells
llow visna virus entry but have a block in virus replica-
ion at a point further downstream in the virus life cycle.
ecause there was no detection of gag PCR product
rom lysates of infected NIH3T3 cells at any of the three
ime points, it is concluded that NIH3T3 cells are non-
FIG. 4. (A) In gel kinase assays performed on NRS or 2-23 immuno-
recipitates prepared from 3T3 (left) or QT6 (right) cells, separated by
DS–PAGE in gels containing the substrate MBP. The arrows indicate
he position of the ;45-kDa kinase. (B) PCR to amplify newly synthe-
ized visna gag DNA in SCP cells (top), QT6 cells (middle), and NIH3T3
ells (bottom). Cells were infected with visna virus or mock infected as
escribed under Materials and Methods, and PCR was performed with
rimers specific to the 59 region of the visna gag gene on cell lysates
repared at the time of infection or 3, 8, or 24 h p.i. Mock lanes are cells
hat were not infected with visna virus. The lane labeled “–” is the PCR
o template control reaction. Products were separated on a 1.5%
D CLEMENTSgarose gel. The gag primers amplify a 141-bp fragment indicated by
he arrows, migrating just above the primer bands in these gels.
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KINASEpermissive to visna virus cell entry (Fig. 4B, bottom). The
nonspecific band below the gag product is the primer
band from the PCR. Collectively, these results appear to
correlate visna virus entry with the presence of the ;45-
kDa kinase.
Visna-susceptible sheep endothelial cells exhibit 2-
23-specific kinase activity
Although not used historically to study visna virus
infection, recent reports from our laboratory have dem-
onstrated that primary brain- and fat-derived sheep en-
dothelial cells (SBECs and SAECs, respectively) can be
productively infected by visna virus in vitro (Craig et al.,
998). To extend our studies of susceptible ungulate
ells, 2-23 immunoprecipitates were processed for in
itro kinase assays or in gel kinase assays as described
bove. The 2-23 immunoprecipitates from both primary
ndothelial cells (ECs) contained the specific ;56-kDa
p in in vitro kinase assays (Fig. 5A). In addition, 2-23-
pecific kinase activity migrating to ;45 kDa was de-
ected in in gel kinase assays of 2-23 immunoprecipi-
ates prepared from both primary ECs (Fig. 5B). In con-
unction with the results presented above, it appears as
f only cells able to support productive visna virus infec-
FIG. 5. (A) In vitro kinase assays of pre-2-23 or 2-23 immunoprecipi-
tates prepared from SAECs (left) or SBECs (right) as described under
Materials and Methods. The arrow indicates the position of the ;56-
kDa pp. (B) SDS–PAGE separation of pre-2-23 or 2-23 immunoprecipi-
tates processed for in gel kinase analysis, through gels containing
MBP. The arrows indicate the position of the ;45-kDa kinase.
SERINE/THREONINEion contain both the ;56-kDa kinase substrate and the
45-kDa kinase.
a
phe 2-23-specific kinase activity is membrane
ssociated in productively infectable ungulate cells
As described above, the 2-23 antiserum was originally
roduced in a rabbit immunized with a membrane pro-
ein isolated from SCPs (migrating between 45 and 50
Da in laboratory-prepared gradient gels) that specifi-
ally bound radiolabeled visna virus (Crane et al., 1991).
n light of immunofluorescence analyses that determined
hat 2-23 specifically labels the surface of visna virus-
usceptible cells and our recent report describing the
bility of 2-23 to both reduce visna virus infection of
CPs and immunoprecipitate a protein complex contain-
ng a membrane-associated proteoglycan (Bruett et al.,
000), we next performed in vitro kinase assays and in
el kinase assays of 2-23 immunoprecipitates prepared
rom membranes isolated from visna virus-susceptible
ells. The ;56-kDa pp was readily detectable in in vitro
kinase assays of 2-23 immunoprecipitates of membrane
proteins prepared from SCPs and GSMs (Fig. 6A). Simi-
larly, in gel kinase assays, performed in parallel from the
same membrane preparations described above, contain
the 2-23-specific ;45-kDa kinase activity (Fig. 6B), sup-
porting the notion that 2-23 immunoprecipitates a com-
plex of membrane-associated proteins containing at
least one serine/threonine kinase. Of note, in experi-
ments in which the kinase activity contained in 2-23
immunoprecipitates of membrane fractions was com-
pared with that contained in 2-23 immunoprecipitates of
FIG. 6. (A) In vitro kinase assays of pre-2-23 or 2-23 immunoprecipi-
tates prepared from membranes isolated from SCPs and GSMs as
described under Materials and Methods. The arrow indicates the
position of the ;56-kDa pp. (B) In gel kinase assays of NRS or 2-23
mmunoprecipitates prepared from membranes isolated from SCPs
nd GSMs and separated by SDS–PAGE through gels containing MBP
325AND VISNA VIRUSs described under Materials and Methods. The arrows indicate the
osition of the ;45-kDa kinase.
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3 TT, ANother cellular fractions (representative of cytoskeletal
aggregates or soluble fractions), the kinase activity was
found to reside predominantly in membranes (i.e., .75%
s assessed autoradiographically; not shown).
he ;56-kDa protein is constitutively phosphorylated
n productively infectable ungulate cells
Finally, in an attempt to evaluate the biological rele-
ance of our observations regarding 2-23 in vitro kinase
ssays and in gel kinase assays, we examined 2-23
immunoprecipitates prepared from SCP cells labeled
with [32P]orthophosphate. Our results (Fig. 7A) indicate
hat 2-23 specifically immunoprecipitates the ;56-kDa
p. Phosphoamino acid analysis of pp56 confirms the
resence of phosphoserine (Fig. 7B). Analysis of the
hosphorylation state of pp46 in these in vivo labeling
tudies were inconsistent over several separate experi-
ents, suggesting, at best, a weak basal level of phos-
horylation of the ;45-kDa protein. This finding is con-
istent with the limited ability of the 45-kDa kinase to
utophosphorylate in vitro (Fig. 3).
DISCUSSION
The cellular receptors for a number of retroviruses and
entiviruses have been identified. Murine leukemia vi-
uses (MLV-E) use a membrane transporter of basic
mino acids (Kim et al., 1991; Wang et al., 1991), whereas
a transporter of neutral amino acids serves as the cel-
lular receptor for both feline and baboon endogenous
retroviruses, as well as for simian type D retroviruses
FIG. 7. (A) SDS–PAGE separation of NRS or 2-23 immunoprecipitates
prepared from SCPs cultured in the presence of [32P]orthophosphate.
he arrows indicates the position of the ;56-kDa pp. (B) Phos-
hoamino acid analysis of the ;56-kDa pp isolated from the 2-23-
pecific lane in the gel represented in A.
26 BARBER, BRUE(Tailor et al., 1999b). Receptors resembling phosphate
transporters have been described for gibbon ape leuke-mia virus (GALV) and feline leukemia virus subgroup B
(FELV-B) (Weiss and Tailor, 1995). Perhaps the most re-
cently hallowed receptors identified for lentiviruses are
chemokine receptors. CXCR4 serves as the primary re-
ceptor for FIV (Willett et al., 1997), and although most
isolates of HIV and SIV require CD4 in concert with a
chemokine receptor (CXCR4 or CCR5 for HIV; CCR5 for
SIV), some strains can utilize chemokine receptors inde-
pendently of CD4 (Broder and Collman, 1997; Broder and
Dimitrov, 1996; Edinger et al., 1997). Despite the progress
of virus receptor identification, both within and outside of
the retrovirus family (Deng et al., 1997; Rasko et al., 1999;
Tailor et al., 1999a; Tailor et al., 1999b), the receptors for
the ungulate lentiviruses, CAEV and visna virus, remain
undefined.
Before the recent emergence of elegant and innova-
tive molecular strategies (Deng et al., 1997), the identifi-
cation of cellular receptors for specific viruses resulted
from varied laborious approaches at the cellular level,
often relying on the use of immunological reagents. To
date, a comprehensive review of the literature on visna
virus pertinent to receptor identification reveals only the
following published observations: (1) Dalziel et al. (1991)
observed that soluble ovine MHC II prevented the bind-
ing of visna virus to a 30-kDa protein on susceptible
cells; however, direct evidence confirming the identity of
the 30-kDa protein as MHC II never materialized. 2)
Studies from our laboratory suggested a role for a ;45-
to ;50-kDa protein as a candidate receptor for visna
virus, based on the cumulative results of a series of
independent experiments (Bruett et al., 2000; Crane et
al., 1991), which ultimately provided the basis for the
experiments presented here. In light of the fact that the
visna virus receptor or receptors have not yet been
identified amidst the evolution of refined molecular tech-
niques, the 2-23 antiserum may represent the only exist-
ing reagent useful for receptor identification. In this re-
gard, characterization of the protein or proteins immuno-
precipitated by 2-23 might influence or even optimize
future strategies, both cellular and molecular, designed
to identify the visna virus receptor and/or coreceptor.
The 2-23 antiserum described above was collected
from a rabbit immunized with the ;45-kDa protein, rep-
resenting one of three membrane proteins (the other two
migrated to 15 and 30 kDa) that bound visna virus spe-
cifically in at least two of three different virus-binding
assays (Crane et al., 1991). In the first assay, lysates
prepared from visna-susceptible and nonsusceptible
cells were separated by SDS–PAGE, transferred to nitro-
cellulose, and incubated with visna virus. Antiserum spe-
cific for visna virus was used to detect the virus-binding
proteins by standard Western analysis. Proteins of ;15
and 30 kDa were the only proteins detected by this
approach, and they were detectable only in visna-sus-
D CLEMENTSceptible cells. In the second assay, cell lysates sepa-
rated by SDS–PAGE through freshly prepared gradient
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KINASEgels were transferred to nitrocellulose and incubated
with visna virus produced by [35S]-labeled cells. Proteins
f ;45 and 15 kDa were detected only in lysates pre-
ared from visna-susceptible cells. In the third assay,
ells iodinated with lactoperoxidase were incubated with
nlabeled virus, after which antiserum specific for gp135
as used to immunoprecipitate protein complexes, which
ere resolved by SDS–PAGE. Proteins of 15, 30, and ;45
Da were specifically detected by this technique.
Polyclonal antisera were subsequently prepared in
abbits immunized with one of the three proteins (15, 30,
nd ;45 kDa). Only one antiserum (2-23), raised against
he ;45-kDa protein, was able to recognize the appro-
riate immunogen by Western analysis, specifically label
he surface of visna virus-susceptible cells, and block the
inding of visna virus to the immunogen present in cell
embranes (Crane et al., 1991). In a more recent study
Bruett et al., 2000), we reported that the 2-23 antiserum
ignificantly reduced visna virus infection of susceptible
ells and specifically immunoprecipitated a complex of
roteins from susceptible cells, which migrated after
DS–PAGE to ;45 and 30 kDa (Bruett et al., 2000). In
ontrast to the ;45-kDa protein, the 30-kDa protein was
ell labeled by [14C] and TRANS[35S]-LABEL, and hence
e were able to characterize this protein biochemically
s a chondroitin sulfate-substituted proteoglycan.
In the present study, we considered the possibility that
he protein complex immunoprecipitated by 2-23 con-
ains kinase activity that facilitates characterization of the
eakly radiolabeled ;45-kDa protein, which in turn may
rovide insight as to the nature of the receptor or recep-
ors themselves. To this end, we compared in vitro ki-
ase assays of 2-23 immunoprecipitates prepared from a
umber of cells susceptible to productive visna virus
eplication (SCPs, GSMs, SBECs, SAECs) and cells non-
usceptible to productive visna virus replication (avian
T6, murine NIH3T3). Resolution of kinase products by
DS–PAGE revealed the presence of both ;45- and
56-kDa pps (phosphorylated predominantly on serine)
n 2-23 immunoprecipitates prepared specifically from
isna-susceptible cells. In gel kinase assays demon-
trated that at least one kinase present in 2-23 immuno-
recipitates is the ;45-kDa protein itself and that this
inase exhibits a limited ability to autophosphorylate. In
ontrast, the ;56-kDa protein exhibited no kinase activ-
ty as assessed by our methods but rather served as a
ajor substrate for serine/threonine kinase activity im-
unoprecipitated by 2-23. Intriguingly, the ;45-kDa ki-
ase activity was detectable in all cells supporting visna
irus entry, whereas the presence of both the ;56-kDa
ajor kinase substrate and the ;45-kDa kinase was
etectable only in cells supporting productive visna virus
eplication. These results strongly implicate the involve-
ent of the ;45-kDa protein in visna virus entry and
SERINE/THREONINEuggest an auxiliary role for the ;56-kDa protein with
egard to productive virus replication. sIn apparent accordance with our in vitro observations,
he ;56-kDa pp was immunoprecipitated specifically by
-23 from [32P]orthophosphate-labeled ungulate cells. As
such, it appears that the ;56-kDa protein is phosphor-
lated (on serine) constitutively, in biologically relevant
usceptible cells. Although it is tempting to speculate
hat the ;56-kDa protein is phosphorylated by the ;45-
kDa kinase, the possibility exists that another kinase
(that does not autophosphorylate or use MBP as a sub-
strate) is also present in 2-23 immunoprecipitates but is
undetectable in our assays. Therefore, careful interpre-
tation of our results with respect to previously described
membrane-associated kinase complexes requires that
we consider both scenarios.
That the ;45- and ;56-kDa pps identified in in vitro
inase assays of 2-23 immunoprecipitates comigrated in
DS–PAGE with the previously described ;45-kDa pro-
ein as well as a novel ;56-kDa protein immunoprecipi-
ated by 2-23 from [35S]/[14C]-labeled susceptible cells
provides a compensatory link between our current ob-
servations and the previously characterized “anti-recep-
tor” activity of 2-23 (Bruett et al., 2000; Crane et al., 1991).
However, the most enticing observation may be the abil-
ity of the 2-23 antiserum (shown previously to label
plasma membranes of susceptible cells by immunocyto-
chemistry; Crane et al., 1991) to immunoprecipitate the
described kinase activity from membrane preparations of
visna-susceptible cells. This finding raises the possibility
that the ;45-kDa visna-binding protein is itself a serine/
threonine kinase.
Given the preponderance of cellular serine/threonine
kinases that are not integral membrane proteins, the
observation that the 2-23 antiserum immunoprecipitates
a protein complex containing serine/threonine kinase
activity may not ensure identification of the visna virus
receptor(s), in that serine/threonine kinases such as
phosphatidylinositol 3-kinase associate with a variety of
membrane receptors (Brennan et al., 1997). However, the
possibility that the receptor is an integral membrane
component of a receptor serine/threonine kinase com-
plex significantly reduces the number of candidate re-
ceptors, which, based on current literature, might resem-
ble a member of the Toll-like receptors or receptors in
the transforming growth factor-b superfamily (Heldin et
al., 1997; Rock et al., 1998). Experiments to address these
ossibilities are currently under way in our laboratory,
ut on a larger scale, the ability of the data acquired from
hese experiments to influence the direction of future
xperiments underscores the potential application of sig-
al transduction to the identification of virus receptors.
MATERIALS AND METHODS
ell culture and reagents
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uch as SCPs, GSMs, SBECs, and SAECs, were obtained
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TT, ANand cultured as described previously (Craig et al., 1998;
Narayan et al., 1977, 1978, 1980). QT6 (quail cells) and
NIH3T3 (murine embryonic fibroblasts), cells that do not
support productive visna virus infection, were obtained
from American Type Tissue Culture (Rockville, MD) and
cultured in Dulbecco’s modified Eagle’s medium (DMEM;
GIBCO BRL, Gaithersburg, MD) containing 10% FBS.
Staurosporine was obtained from Calbiochem (La Jolla,
CA), and MBP was obtained from Upstate Biotechnology
Incorporated (UBI; Lake Placid, NY). Minimum essential
medium with Earle’s salts (EMEM), DMEM, and MEM-
Select-amine kit ([14C] labeling media and [14C]/[35S] la-
eling media) were obtained from GIBCO BRL. [14C] la-
beling media was supplemented with L-tryptophan, L-
glutamine, L-methionine, and L-cysteine and prepared
according to manufacturer’s instructions for the MEM-
Select-amine kit. [14C]/[35S] labeling medium was pre-
ared from the MEM-Select-amine kit and supplemented
ith L-tryptophan and L-glutamine. FBS was obtained
from Atlanta Biologicals (Norcross, GA). Visna virus
strain 1514 was prepared as previously described (Cork
et al., 1974; Narayan et al., 1978; Pyper et al., 1984).
Antisera
Polyclonal antiserum 2-23, was collected from a rabbit
immunized with the ;45-kDa membrane-associated
visna virus binding protein described previously (Crane
et al., 1991). Preimmune serum from this rabbit is desig-
nated pre-2-23. Due to the limiting amount of pre-2-23,
NRS (Jackson ImmunoResearch Laboratories Inc., West-
grove, PA) was used in some experiments.
Metabolic labeling of cells
Cells were labeled as previously described (Barber et
al., 1998; Bruett et al., 2000), either with [32P]orthophos-
phate (NEN Life Sciences Products, Boston, MA) or with
a combination of TRANS[35S]-LABEL (ICN Pharmaceuti-
als, Irvine, CA) and L-[14C(U)]amino acids (NEN Life
Science Products). Briefly, subconfluent cell cultures
were incubated for 1 h in phosphate-free media (Life
Technologies) or media lacking the relevant amino acids
(above), after which 55 mCi/ml [32P]orthophosphate or 70
nd 10 mCi/ml, respectively, of TRANS35S-LABEL and
L-[14C(U)]amino acids were added to overnight cultures.
The next day, cell lysates were prepared and processed
as described below.
Immunoprecipitations and in vitro kinase assays
Cells were washed with ice-cold PBS and lysed on ice
for at least 15 min in 3-[(3-cholamidopropyl)dimethylam-
monio]propanesulfonate (CHAPS)-based lysis buffer (50
mM Tris–HCl, pH 7.7, 6.5 mM CHAPS, 150 mM NaCl, 2
mg/ml aprotinin, 100 mM leupeptin, 1 mM sodium or-
328 BARBER, BRUEhovanadate), after which the lysates were collected by
entle scraping and incubated on ice for an additional–3 h. Insoluble cellular material was pelleted at 14,000
pm for 5 min, and the clarified supernatants were as-
ayed for protein content using the Bio-Rad protein as-
ay kit (Hercules, CA). Equivalent amounts of protein
ere incubated with pre-2-23 or 2-23 antisera and ro-
ated overnight at 4°C. Protein G–Sepharose (Amer-
ham, Arlington Heights, IL) was added (at 4°C) for an
dditional 1–2 h to capture the immunoprecipitates. Im-
unoprecipitates prepared from metabolically labeled
ells were washed four times with CHAPS-based lysis
uffer, separated by standard 9% SDS–PAGE, fixed (20%
sopropanol–10% acetic acid) for 1 h, rinsed three times
n deionized water, incubated for 45 min in 1 M sodium
alicylate, dried, and subjected to autoradiography using
odak X-OMAT blue (NEN Life Sciences Products) or
ioMax MR or MS film (VWR; Bridgeport, NJ). Immuno-
recipitates used in in vitro kinase assays were washed
hree times with CHAPS-based lysis buffer and once in
inase buffer (50 mM Tris–HCl, pH 7.7, 20 mM MnCl2, 20
M MgCl2, 1 mM dithiothreitol) and incubated for 20 min
n kinase buffer containing 200 mM [g-32P]ATP (3000
mCi/mmol; NEN). Kinase products were washed once
with CHAPS-based lysis buffer before separation by
SDS–PAGE and autoradiography.
In gel kinase assays
Immunoprecipitates were washed four times with
CHAPS-based lysis buffer, separated by SDS–PAGE in
gels containing 200 mg/ml MBP or no substrate, and
rocessed for in gel kinase activity essentially as de-
cribed (Yang and Gabuzda, 1998). Briefly, the gels were
ncubated twice for 1 h in buffer 1 (50 mM Tris–HCl, pH
.7, 20% isopropanol), 1 h in buffer 2 (50 mM Tris–HCl, pH
.7, 5 mM 2-ME), 1 h in buffer 3 (7.5 M guanidine HCl in
uffer 2), and overnight in buffer 4 (buffer 2 containing
.04% Tween 20). The next day, the gels were incubated
n kinase buffer (50 mM Tris–HCl, pH 7.7, 150 mM NaCl,
0 mM MnCl2, 20 mM MgCl2) for 1 h before the addition
of 150 mCi of [g-32P]ATP (3000 mCi/mmol; NEN) for 1 h.
he gels were washed extensively in 5% trichloroacetic
cid–1% sodium pyrophosphate, dried, and exposed for
utoradiography. In in gel kinase assays performed in
he presence of kinase inhibitors, staurosporine,
enistein, or DMSO (vehicle control) were added at the
ndicated concentrations to buffer 4 and the kinase
uffer.
hosphoamino acid analysis
Phosphoamino acid analysis of phosphorylated pro-
eins was performed essentially as described previously
Barber et al., 1998). Briefly, pps identified by autoradiog-
raphy were extracted from the rehydrated polyacryl-
amide gels, trypsinized, and subjected to acid hydrolysis
D CLEMENTSbefore separation by thin-layer chromatography electro-
phoresis.
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Isolation of cellular membranes was performed essen-
tially as described (Bhat et al., 1999; Jesaitis et al., 1982;
Sambrook et al., 1971). Briefly, adherent cells were re-
leased in 1 mM EDTA–PBS at 4°C for ;2 h, pelleted
(2000 rpm, 5 min), resuspended in homogenization buffer
(25 mM HEPES, pH 7.3, 0.5 mM EGTA, 0.5 mM sodium
orthovanadate, 0.1 mM sodium molybdate, 1 mM sodium
fluoride) containing protease inhibitors (2 Complete tab-
lets/50 ml; Boehringer-Mannheim, Mannheim, Germany),
and subjected to Dounce homogenization. The homog-
enates were centrifuged at 4°C for 5 min at 1000 g to
remove unlysed cells, for 7 min at 10,000 g to remove
aggregates of cytoskeletal components, and for 2 h at
69,000 rpm to pellet the membranes. Membrane proteins
were extracted (overnight at 4°C) with CHAPS-based
lysis buffer (3 ml), concentrated using Amicon Centricon3
protein concentrators (Millipore Corp., Bedford, MA), and
quantified as described above.
Analysis of viral entry
SCP, NIH3T3, or QT6 cells plated and grown to ;90%
confluency in 12-well culture plates were infected for 3 h
with visna virus (106 TCID50; in EMEM plus 0.5% FBS) that
ad been incubated with 20 mg/ml RQ1 DNase (Pro-
ega, Madison, WI) at 37°C for 30 min in the presence
f 10 mM MgCl2 and clarified through a 0.45-mm filter.
ninfected cells were treated exactly as infected cells
xcept that EMEM plus 0.5% FBS alone was DNase
igested, filtered, and added to mock wells. After 3 h, all
ells were washed three times with EMEM plus 0.5%
BS (to remove virus), and medium was replaced with
MEM plus 0.5% FBS. Immediately after infection, the
ero time point was taken. At each time point (0, 3, 8, and
4 h p.i.), cells were washed two times with PBS,
craped into 1 ml of PBS, and pelleted in a tabletop
icrocentrifuge. Cell pellets were lysed in 150 ml of PCR
lysis buffer [50 mM KCl, 10 mM Tris–HCl, pH 8.3, 1.5 mM
MgCl2, 0.001% gelatin, 0.45% Nonidet P-40, 0.45% Tween
0, and 20 mg/ml Proteinase K (Boehringer-Mannheim,
Indianapolis, IN)] and incubated first at 55°C for 90 min
and then at 99°C for 10 min to inactivate the Proteinase
K. Viral DNA was detected by PCR (5 min at 99°C, 45 s
at 60°C, 2 min at 72°C followed by 35 cycles of 1 min of
denaturation 94°C, 45 s of annealing at 60°C, and 45 s of
extension at 72°C) of 25 ml of lysate in a 50-ml reaction
mix containing primers specific for the 59 end of the visna
gag gene (59-CTAGCTAGAGACATGGCGAAGC-39 and 59-
TAATGCCCATAGACAATTCCCTT-39). Resultant PCR prod-
ucts were separated on a 1.5% agarose gel.
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